Last reviewed · How we verify
paracetamol, tramadol, and ondansetron — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
paracetamol, tramadol, and ondansetron (paracetamol, tramadol, and ondansetron) — Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| paracetamol, tramadol, and ondansetron TARGET | paracetamol, tramadol, and ondansetron | Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- paracetamol, tramadol, and ondansetron CI watch — RSS
- paracetamol, tramadol, and ondansetron CI watch — Atom
- paracetamol, tramadol, and ondansetron CI watch — JSON
- paracetamol, tramadol, and ondansetron alone — RSS
Cite this brief
Drug Landscape (2026). paracetamol, tramadol, and ondansetron — Competitive Intelligence Brief. https://druglandscape.com/ci/paracetamol-tramadol-and-ondansetron. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab